ACTIVE

Inteliphage

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-2 M €-81,2 %over 1 year

Revenue22,5 k €

Equity3,2 M €+96,5 %over 1 year

Workforce16,1 ETP+33,1 %over 1 year

Identity

Source · BCE/KBO

Inteliphage is a Private limited company incorporated in 2018. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Ottignies-Louvain-la-Neuve. It employs on average 16,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0692.975.522
Incorporation: 27/03/2018
Legal form: Private limited company
Registered office: Avenue Jean Monnet 1
1348 Ottignies-Louvain-la-Neuve · WallonieSee on map
Contributed capital: 3 877 730,00 €
Latest accounts: 31/12/2025
Average workforce: 16,1 ETP

Activities (NACE)

21100Manufacture of basic pharmaceutical products· main 21100Manufacture of basic pharmaceutical products 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

Good liquidityHealthy social debts

Financials

Source · NBB, 7 filings

Trend over 7 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	22,5 k €		–		–		–		–
EBITDA	-1,7 M €	-83.1%	-952,5 k €	+32.4%	-1,4 M €	-109%	-673,3 k €	-84.6%	-364,7 k €
Operating result	-1,9 M €	-76.9%	-1,1 M €	+29.4%	-1,5 M €	-111%	-719,6 k €	-97.3%	-364,7 k €
Net result	-2 M €	-81.2%	-1,1 M €	+28.5%	-1,6 M €	-107%	-752,2 k €	-106%	-365,9 k €
Balance sheet
Equity	3,2 M €	+96.5%	1,6 M €	+2.4%	1,6 M €	+290%	-834,5 k €	-134%	-356,2 k €
Total assets	12,6 M €	+62.5%	7,8 M €	+42.1%	5,5 M €	+103%	2,7 M €	+173%	990,3 k €
Cash	597,2 k €	+146%	242,7 k €	+95.0%	124,5 k €	-7.5%	134,6 k €	-85.5%	931,6 k €
Debts	9,5 M €	+53.5%	6,2 M €	+58.3%	3,9 M €	+15.6%	3,4 M €	+150%	1,3 M €
Other
Workforce	16,1 ETP	+33.1%	12,1 ETP		–		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sylvie Rauel	Directorsince 24/12/2025
Anjac SASRepresented by Emmanuelle Raillard-Labbé	Directorsince 02/09/2025
CENTIVIARepresented by Charles Perrard	Managing directorsince 23/06/2025
Emmanuel Caeymaex	Chairman of the board of directorssince 23/06/2025Director02/05/2024 → 2024 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Anjac SAS SARepresented by Trippltelli SOPHIE	Director29/06/2023 → 2024 accounts
Gunther Vanwezer	Managing director29/06/2023 → 2024 accounts
Guillaume de Viron	Director08/02/2022 → 2024 accounts
Jerôme Majoie	Director08/02/2022 → 2024 accounts

Other companies at this address

Avenue Jean Monnet 1 1348 Ottignies-Louvain-la-Neuve

Company	CBE no.
AIR VISION● Active	0466.468.644
ARK Capture Solutions● Active	1009.117.031
Bâtisseurs d'Etoiles● Active	0763.364.660
BETA Systems Software● Active	0460.900.052
Charmoz Invest● Active	1025.992.754
CHEMIUM● Active	0640.872.565
ChemoSensoryX Biosciences SA● Active	0867.817.428
DNAlytics● Active	0844.973.235
FEMAG● Active	0566.972.126
GO-PME● Active	0717.854.636
HEXION RESEARCH BELGIUM SA● Active	0469.529.092
LAPORTE EURO● Active	0767.819.732
Logstail Belgium● Active	1036.995.128
MINAGRO● Active	0739.988.353
SABCA Technologies● Active	0790.626.214
SiPulse● Active	1040.681.722
SUNSWITCH● Bankrupt	0890.449.112
Venturi Holding● Active	1029.462.879

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/07/2026	24/10/2025	27/11/2024	22/11/2023	10/10/2022	30/08/2021
General meeting	29/06/2026	17/09/2025	07/11/2024	12/09/2023	24/08/2022	07/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 7 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	13/07/2026	French	PDF
Abridged model	31/12/2024	17/09/2025	24/10/2025	French	PDF
Micro model	31/12/2023	07/11/2024	27/11/2024	French	PDF
Micro model	31/12/2022	12/09/2023	22/11/2023	French	PDF
Micro model	31/12/2021	24/08/2022	10/10/2022	French	PDF
Micro model	31/12/2020	07/06/2021	30/08/2021	French	PDF
Micro model	31/12/2019	02/06/2020	31/08/2020	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 9 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Sylvie Rauel	Directorsince 24/12/2025
Anjac SASRepresented by Emmanuelle Raillard-Labbé	Directorsince 02/09/2025
CENTIVIARepresented by Charles Perrard	Managing directorsince 23/06/2025
Emmanuel Caeymaex	Chairman of the board of directorssince 23/06/2025Director02/05/2024 → 2024 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Anjac SAS SARepresented by Trippltelli SOPHIE	Director29/06/2023 → 2024 accounts
Gunther Vanwezer	Managing director29/06/2023 → 2024 accounts
Guillaume de Viron	Director08/02/2022 → 2024 accounts
Jerôme Majoie	Director08/02/2022 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/10/2026
Révocation mandat spécial
PDF
Mandates10/02/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates09/01/2026
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Mandates12/12/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates24/01/2025
SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
PDF
Mandates22/05/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates22/05/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates21/09/2023
DIVERS - DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings7 filings

Mandates

Sylvie Rauel

Anjac SAS

CENTIVIA

Emmanuel Caeymaex

Anjac SAS SA

Gunther Vanwezer

Mehdi El Glaoui

Jerôme Majoie

Guillaume de Viron

Olivier Poswick

Vesale Invest SLU

Anjac SAS

Show the other mandate

201820192020202120222023202420252026

InteliphageInteliphage (anciennement Vesale Bioscience)

Avenue Jean Monnet 1, 1348 Louvain-la-NeuveRue Grandbonpré - Bâtiment Watson H 11, 1435 Mont-Saint-Guibert

Managing director

Chairman of the board of directors

Director

Managing director

Director

Managing director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Avenue Jean Monnet 1, 1348 Louvain-la-NeuveCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00292141
Rue Grandbonpré - Bâtiment Watson H 11, 1435 Mont-Saint-Guibert	accounts 2022 → 2023	Accounts 2023 · 2024-00608677
Rue Louis Allaert 9, 5310 Eghezée	accounts 2021	Accounts 2021 · 2022-20455489

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
InteliphageCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00292141
Inteliphage (anciennement Vesale Bioscience)	accounts 2022 → 2023	Accounts 2023 · 2024-00608677
Vésale Bioscience	accounts 2021	Accounts 2021 · 2022-20455489

Events

2025
Annual accounts 2025-2 M €↓
2024
Annual accounts 2024-1,1 M €↑
2024
Name changeInteliphage
2023
Annual accounts 2023-1,6 M €↓
2022
Annual accounts 2022-752,2 k €↓
2022
Name changeInteliphage (anciennement Vesale Bioscience)
2021
Annual accounts 2021-365,9 k €↓
2020
Annual accounts 20205,1 k €↑
2019
Annual accounts 2019-1,5 k €
27/03/2018
IncorporationPrivate limited company

Inteliphage

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events